Martin Shkreli, the former hedge fund manager known as "Pharma Bro," defended Palantir Technologies Inc.'s valuation on Tuesday amid the company's surging stock price, projecting substantial cash flow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback